Educational Resources
Published Manuscripts:
CE Measures
American Journal of Medical Quality
Med-IQ Speakers Bureau:
Invite a CME expert to speak at your next event
|
BALTIMORE, MD—June 25, 2012—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), and The Endocrine Society, the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology, are pleased to announce the results of a study demonstrating improved patient outcomes from clinician participation in their collaborative diabetes performance improvement (PI) education. These results will be presented at ENDO 2012: The 94th Annual Meeting & Expo, tomorrow, June 26, in Houston.
"We will share results of what we believe to be one of the first studies evaluating the effect of clinician participation in PI-CME on patient health and the difference in patient health outcomes when clinicians complete other types of non-performance based education," said Scott Weber, co-CEO of Med-IQ.
Session Title: Health Outcomes, Professional Education, & HealthCare Delivery Research
Presenter: Sara C. Miller, MS, Assistant Director of Educational Strategy, Med-IQ
Date: Tuesday, June 26, 2012
Time: 11:15 AM
Room: 360, George R. Brown Convention Center
Diabetes is a growing epidemic with nearly one-third of adults in the United States predicted to have this disease by the year 2050. Unfortunately, as few as 12 percent of patients are able to reach combined treatment goals for hemoglobin A1C (HbA1C), blood pressure (BP), and cholesterol. In 2008, Med-IQ and The Endocrine Society partnered to develop Performance Improvement Strategies in Diabetes, an AMA-style PI CME activity focused on the care of patients with type 2 diabetes.
Within the first three years, 278 clinicians completed the PI CME activity in diabetes, and significant improvements in physician clinical practice performance have been previously published. However, the results reported tomorrow will demonstrate the direct, positive effect that this PI CME activity has had on the patients of physicians who engaged in it.
"The performance changes observed in our PI CME activities have been gratifying and are certainly important. However, until now we did not have data to support the idea that clinician performance changes directly correlate with the true desired outcomes from any PI CME activity: improved patient health," said Howard Baum, MD, Clinical Professor of Medicine at UT Southwestern, Dallas Diabetes & Endocrine Center, and the faculty chair for this study.
To more fully elucidate the effect of diabetes-focused PI CME on patients, Med-IQ conducted a research study in the spring and summer of 2011, supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY. Evaluating patient-level data from a cohort of PI CME participants, the specific aims of this study were to:
- Evaluate the effect of completion of the three stages of diabetes-focused, AMA-style PI CME activity on patient health
- Evaluate the patient health effect of participation in traditional CME activities compared to PI CME
- Assess the value of the final chart review in PI on patient outcomes
- Determine critical barriers to the completion of PI and participant perspectives regarding the effect on clinical practice
- Explore the hypothesis that PI completers represent a sub-group of practitioners who are more aligned with national standards of diabetes care
"Reviewing the records of more than 300 patients, we are pleased to report a positive and significant correlation between PI CME completion and patient health. Most importantly, study results indicated that patients of doctors who participate in diabetes PI CME had significant improvements in A1C levels," said Dr. Baum.
"We believe the results of this study are important given the increasing emphasis placed on quality improvement as a component of maintenance of certification, the expanding diabetes epidemic, the increasing demands on physician time, and decreasing resources for the development of CME activities, particularly those geared toward higher-level performance outcomes," Dr. Baum said.
This PI CME activity was supported by an educational grant from Sanofi-aventis U.S. Inc., A SANOFI COMPANY.
About Med-IQ
Med-IQ, America’s most respected provider of continuing medical education (CME), inspires healthcare professionals through activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ received the Alliance for Continuing Education in the Health Professions' President’s Award (2012), Award for Outstanding CME Outcomes Assessment (2012), and William Campbell Felch Award for Outstanding Research in CME (2011). Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively. We are a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives. To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, connect with us on LinkedIn, and visit our YouTube channel.
About The Endocrine Society
Founded in 1916, The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society's membership consists of over 15,000 scientists, physicians, educators, nurses, and students in more than 100 countries. Together, these members represent all basic, applied, and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, MD, and has earned Accreditation with Commendation from the Accreditation Council for Continuing Medical Education (ACCME). To learn more about the Society, and the field of endocrinology, visit our Web site at www.endo-society.org.
For more information, contact:
|
close
